Search

Search Constraints

You searched for: Author/Creator Xu, Cong

Search Results

3. 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results. (10th December 2020)

4. 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results. (9th November 2020)

7. A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis. Issue 1 (3rd December 2020)